Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
Abstract Plasma and serum are rich sources of information regarding an individual's health state, and protein tests inform medical decision making. Despite major investments, few new biomarkers have reached the clinic. Mass spectrometry (MS)‐based proteomics now allows highly specific and quant...
Main Authors: | Philipp E Geyer, Eugenia Voytik, Peter V Treit, Sophia Doll, Alisa Kleinhempel, Lili Niu, Johannes B Müller, Marie‐Luise Buchholtz, Jakob M Bader, Daniel Teupser, Lesca M Holdt, Matthias Mann |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-11-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201910427 |
Similar Items
-
Revisiting biomarker discovery by plasma proteomics
by: Philipp E Geyer, et al.
Published: (2017-09-01) -
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
by: Philipp E Geyer, et al.
Published: (2021-08-01) -
Molecular functions and specific roles of circRNAs in the cardiovascular system
by: Lesca M. Holdt, et al.
Published: (2018-06-01) -
Strategies for increasing frataxin expression in Friedreich's ataxia: modulation of the epigenome and proteome
by: Quinlan, R
Published: (2021) -
Animal- versus in vitro-derived antibodies: avoiding the extremes
by: Andrew R.M. Bradbury, et al.
Published: (2021-01-01)